Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.54
- Piotroski Score 6.00
- Grade Sell
- Symbol (CLB)
- Company Core Laboratories N.V.
- Price $21.27
- Changes Percentage (0.71%)
- Change $0.15
- Day Low $21.09
- Day High $21.77
- Year High $25.13
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
- Last Earnings 10/23/2024
- Ex-Dividend for 5/16 Dividend 11/04/2024
- Dividend Payable 11/25/2024
- Today N/A
- Next Earnings (Estimated) 01/29/2025
- Fiscal Year End N/A
- Average Stock Price Target $26.00
- High Stock Price Target $32.00
- Low Stock Price Target $17.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.51
- Trailing P/E Ratio 35.78
- Forward P/E Ratio 35.78
- P/E Growth 35.78
- Net Income $36.68 M
Income Statement
Quarterly
Annual
Latest News of CLB
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Is Cellebrite (CLBT) Poised to Develop And Sell The Next Generation Of AI Analytics Tools?
Greenhaven Road Capital's Q3 2024 investor letter highlighted Cellebrite DI Ltd. (NASDAQ:CLBT), a software company that develops solutions for investigations. The stock had a one-month return of -1.05...
By Yahoo! Finance | 1 week ago -
Core Laboratories Inc (CLB) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
CEO Lawrence Bruno discusses Core Lab's involvement in CCS projects focusing on CO2 introduction effects, emphasizing expertise from EOR studies. Pulverize technology shows promise in reducing costs a...
By Yahoo! Finance | 4 weeks ago -
Core Laboratories (CLB) Q3 2024 Earnings Call Transcript
Core Labs discussed strategies, financial tenets, and operational highlights in their Q3 2024 earnings call. They highlighted revenue growth, challenges, debt reduction, and future outlook, focusing o...
By Yahoo! Finance | 1 month ago
